This site uses cookies to store information on your computer. Learn more x

DSM in Medical

DSM announces full-scale operation of its US Dyneema Purity® fiber plant as well as the launch of the world’s thinnest UHMWPE fiber, Dyneema Purity 10 dtex fiber

Exton PA, US, 11 Feb 2014 13:02 CET

DSM’s Greenville, NC plant, dedicated for medical fiber manufacturing, begins production of the world’s thinnest, high-strength, medical-grade UHMWPE fiber, Dyneema Purity® 10 dtex fiber

DSM, a global leader in biomedical materials science and regenerative medicine, today announced that the company’s Greenville, North Carolina facility is fully operational, running and qualified. Furthermore, DSM is expanding its Dyneema® Purity fiber portfolio and is commercially launching the thinnest, high-strength, medical-grade UHMWPE fiber available on the market, Dyneema Purity 10 dtex fiber. The fiber will be available in both white and blue.

DSM’s Greenville, NC facility demonstrates the company’s commitment to the medical market. It is the only plant of its kind dedicated solely to the production of medical-grade fibers. The site is ISO 13485:2003 certified, continuing DSM’s longstanding tradition of maintaining facilities with quality management systems that consistently meet customer requirements and regulatory requirements applicable to medical device manufacturing and related services. In addition, the plant implements DSM’s latest technological and environmental advances, which promote energy efficiency. Latest technology manufacturing processes result in lower emissions and support a much more efficient use of raw materials and processing techniques compared to standard plants. 

Next to 10 dtex fibers, the Dyneema Purity fiber production line will produce various grades for cardiovascular applications, including Dyneema Purity TG 25 dtex fiber, which offers the same strength as existing grades at thinner diameters, and the Dyneema Purity SGX fibers. Dyneema Purity UG fibers will also be produced in Greenville, developed specifically to allow the development of strong, stable orthopedic implants that provide consistent performance. 

Introducing Dyneema Purity 10 dtex fiber

Starting this month, DSM commercialized its Dyneema Purity 10 dtex fiber and launched production exclusively at the Greenville, NC facility. The fiber is four times stronger than polyester and thinner than any other UHMWPE medical fiber on the market. The high quality manufacturing processes for the fiber benefit from the facility’s unique specialization in medical-grade manufacturing.

In 2012, the global minimally invasive surgery market was valued at approximately $25 billion and is expected to grow at a CAGR of 10.5% during the forecast period 2013 to 2019 to reach a market value of over $50 billion by 20191.  Minimally invasive surgical procedures typically result in less discomfort and faster recovery times for patients. As such, medical device makers seek materials that enable the production and design of devices with tinier profiles. The Dyneema Purity 10 dtex fiber’s fine denier promotes the design of smaller devices without compromising strength and durability.

The initial application of the material is in cardiovascular sutures, which will enable surgeons to reach new patient groups with smaller or blocked veins and arteries. Other application focus areas include transcatheter heart valves (TAVI/TAVR systems) and Abdominal and Thoracic Aortic Aneurysm stent grafts. 

Our Greenville, NC facility is focused on the manufacturing of medical-grade fiber and all of the technology implemented at the facility is proprietary to DSM and leverages our decades-long history of materials innovation,” said Carola Hansen, Director of Biomedical Polyethylenes, DSM Biomedical. “We are proud to bring to market our new Dyneema Purity 10 dtex fiber, the thinnest medical-grade material of its kind, and look forward to seeing it used by medical device manufacturers to innovate new technology that helps patients and surgeons.”

1 Minimally invasive surgery market is expected to reach USD 50.60 billion globally in 2019: Transparency Market Research. (2014, January 6). Retrieved January 7, 2014, from http://www.prnewswire.com/